Biography of Matthew Roden
Last update: March 1, 2024Career
Matthew was Executive Partner at MPM Capital, and Senior Vice President and Head of Enterprise Strategy at Bristol Myers Squibb.
Matthew Roden is currently- Director, President and Chief Executive Officer at Aktis Oncology - View - Aktis Oncology org chart
- Executive Partner at MPM Capital - View - MPM Capital org chart
Create your alert
to follow the career of Matthew Roden.
Education
Matthew Roden has a Master of Science from Georgetown University and a PhD from Albert Einstein College of Medicine.
They have also studied at Georgetown University :
Find more alumni from Georgetown University
More about Matthew Roden
Selected links
Do you need to know more about Matthew Roden? More results.
Participate
Social media
- Matthew Roden on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Matthew Roden
The colleagues of Matthew Roden
Company Colleagues
- At Aktis Oncology, Matthew Roden has 16 colleagues including Lloyd Segal (Director), Oleg Nodelman (Director)…
- At MPM Capital, Matthew Roden has 20 colleagues including Ansbert Gadicke (BioImpact), Todd Foley (Biotech)…
Industry Colleagues
- In the Fund industry, Matthew Roden has 21,690 colleagues in 1,474 companies located in 63 countries. 9,261 executive movements have been recorded in the last 12 months. Learn more about Fund.
Report an error
Update the org chart details of Matthew Roden.
Get in Touch
and ask for Matthew Roden.
